Novonix Income Statement (2020-2025) | NVNXF

Income Statement Jun2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025
Revenue & cost
Revenue (Quarter) 0.00B0.00B0.00B
Operating items
Research & Development (Quarter) -0.00B-0.00B-0.00B
Share-based Compensation (IS) (Quarter) 0.01B
Restructuring Costs (Quarter) -0.01B-0.01B-0.01B
Operating Expenses (Quarter) -0.01B-0.01B-0.01B
EBIT (Quarter) -0.03B-0.03B-0.03B
Non-operating items
Interest & Investment Income (Quarter) 0.00B0.00B
Other Non Operating Income (Quarter) 0.00B0.00B0.00B0.00B
Non Operating Income (Quarter) 0.00B
Net income details
EBT (Quarter) -0.03B-0.03B-0.03B
Profit After Tax (Quarter) -0.03B-0.03B-0.03B-0.03B
Income from Continuing Operations (Quarter) -0.03B-0.03B-0.03B
Consolidated Net Income (Quarter) -0.03B-0.03B-0.03B
Income towards Parent Company (Quarter) -0.03B-0.03B-0.03B
Net Income towards Common Stockholders (Quarter) -0.03B-0.03B-0.03B
Additional items
EPS (Basic) (Quarter) -0.090.000.00
EPS (Weighted Average and Diluted) (Quarter) -0.090.000.00
Shares Outstanding (Weighted Average) (Quarter) 0.07B0.28B0.32B0.33B486.62B338.16B487.47B338.43B367.54B392.84B681.68B
Shares Outstanding (Diluted Average) (Quarter) 0.28B0.32B0.33B486.62B487.47B496.86B
EBITDA (Quarter) 0.04B-0.03B-0.03B